Comorbidity and it,s Impact on COVID-19 Affected Patients in COVID-19 Dedicated Hospital of Bangladesh

Hossain, Irin; Mullick, Ashekur Rahman; Khan, Manzurul Haque; Halim, Kazi Shafiqul; Aktaruzzaman, M. M.; Nabi, Shah Golam; Rahman, SM Tajdit; Shahin, Md.

doi:10.3329/bmj.v49i1.52585

Cited by 11 publications

(12 citation statements)

References 25 publications

(47 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are significant differences between Bangladesh, China and the US in population demographics, smoking rates, and prevalence of comorbidities. 17 Consistent with recent reports 8 , the percentage of patients with co morbid renal disease and malignancy was relatively low as also found in our study. Our findings have therefore added to the existing literature on the spectrum of co morbidities in patients with COVID-19 based on the larger sample sizes and representativeness of the whole patient population in Bangladesh.…”

supporting

confidence: 93%

Death review caused by Covid 19 in Bangladesh

Biswas

Nath

Nisha

2022

Preprint

View full text Add to dashboard Cite

Introduction: COVID- 19 pandemic had taken away lots of human life prematurely worldwide and death laid its icy hands also on Bangladesh. So, objectives of this study were to explore the monthly distributions, age, sex, co-morbidities, localities and duration of hospital stay among the COVID death cases. Methods: In this observational study six months hospital death files were collected and explored for monthly distributions, age, sex, co-morbidities, localities and hospital stay. RT-PCR positive confirmed 113 COVID deaths were enrolled and suspected COVID deaths were excluded. Ethical clearance from the hospital authority was taken before hand. Data was compiled and analyzed by SPSS-20. Results: There was a low frequency of death in May-2021 and October-2021(7.1% and 2.7% respectively) but more during June -2021 to September 2021 (12.4%, 16.8%, 42.5% and 18.6% respectively). Female deaths were little more than male deaths(53.1% vs 46.9%). Age more than 51 years were the most vulnerable where 26(23%) deaths were at age group 51- 60 years, 39(34.5%) deaths were at 61-70 years and 22(19.4%) deaths were more than 71 years. Mean age of death was found 60.66 years and mean duration of hospital stay was found 9.45 days. Maximum duration of hospital stay was 45 days for one patient. Co-morbidities of death cases revealed 52(46.00%) patients had DM and HTN both, 17(15.0%) patients had HTN, 16(14.1%) had DM, 3(2.6%) had BA and COPD, 4(3.5%) had CKD, 2(1.7%) had cancer, 3(2.6%) had CVD, 19(16.8%) had IHD and 16(14.1%) patients had no co-morbidities. Locality of the death cases revealed 44(38.9%) came from rural areas and 69(61.1%) came from urban areas. Conclusion: Higher age group and multiple co-morbidities specially DM, HTN and IHD were related with COVID deaths mostly found in our study.

show abstract

supporting

confidence: 93%

Death review caused by Covid 19 in Bangladesh

Biswas

Nath

Nisha

2022

Preprint

View full text Add to dashboard Cite

show abstract

“…Our findings noted hypertension and diabetes were the most common comorbid condition among the cases admitted in hospitals in Bangladesh and elsewhere (M.J. Hasan, Anam, et al 2021; I. Hossain et al 2020; Mowla et al 2020). This finding reaffirmed observations reported in previous studies.…”

Section: Discussionmentioning

confidence: 51%

Clinical manifestations of hospitalized COVID-19 patients in Bangladesh: a 14-day observational study

Shaha

Islam²,

Huq³

et al. 2021

Preprint

View full text Add to dashboard Cite

Objectives: Severe acute respiratory coronavirus-2 (SARS-CoV-2) is currently a significant public health concern and causing a pandemic in the world. Despite of immense attention to the coronavirus disease-2019 (COVID-19), very little attention has been given to the kinetics of disease progression in infected patients. Therefore, in this study, we present a 14-day clinical observation of hospital-admitted COVID-19 patients. Methods: After recording the demography of 42 COVID-19 patients on day 1, we observed the clinical progression for 14 days by investigating the hematological and biochemical responses of patients blood and serum, respectively. Results: Approximately 62% of the hospital-admitted COVID-19 patients presented cough, followed by fever (approximately 52%). The top comorbidities of these patients were hypertension (30%) and diabetes mellitus (19%). The average blood hemoglobin level was slightly low among the patients in early days of infection and went up to the normal level on the latter days. A substantial increase in the level of ALT/SGPT (up to 106 units/L; SEM: 12.64) and AST/SGOT (up to 64.35 units/L; SEM: 5.013) in COVID-19 patients was observed, which may suggest that infection with CoV-2019 is associated with the functionality of other organs of COVID-19 patients. Conclusion: This 14-day observational study may help clinicians to decide the choice of treatment of COVID-19 patients.

show abstract

“…Overall, 307 (75.8%) patients were discharged alive, 98 (24.2%) patients expired, 63 (15.6%) were shifted to the ICU and 16 (4.0%) were put into invasive ventilation. [25] In our study period, total 205 patients were admitted. Among them 152 had comorbidities out of which 70 patients had ≥2 comorbidities.…”

Section: Discussionmentioning

confidence: 97%

The Outcome of Covid-19 Positive Patients in a Covid Dedicated ICU, Associated with Comorbid Diseases: A Cross-Sectional Study

Arefin¹

2022

AIMDR

View full text Add to dashboard Cite

Background: Patients with Coronavirus Disease (COVID-19) have a significant death rate due to comorbid diseases. As a result, identifying risk factors associated with poor outcomes in COVID-19 patients is important. Objective: The aim of this study was to evaluate the admission and outcome status of the patients confirmed with Covid-19.Material & Methods:This cross-sectional study was conducted at Mugda Medical College & Hospital, Dhaka, Bangladesh during the period from April 2020 to September 2020. Total 205 patients with covid-19 were included in this study. Collection of data were checked and cleaned. After cleaning, the data were entered into computer and statistical analysis of the results being obtained by using windows-based computer software devised with Statistical Packages for Social Sciences version 24.Results:In this study among 205 patients. Most of the study people 41(20.0%) confirmed with covid-19 were admitted in September 2020. Followed by 20(9.76%) in April 2020, 33(16.09%) in May 2020, 35(17.07%) in June 2020, 38(18.53%) in July 2020, 37(18.04%) in August 2020 and 41(20.0%) in September. 23(11.21%) highest death with covid-19 were admitted in July 2020. Most of the patients 104(50.73%) were discharged with advice and 101(49.26%) patients had expired. Out of 101 expired patients 92 (91%) had comorbidities. The most common comorbidity amongst ICU admitted patients was respiratory syndrome (55 in number) and least common was hypertension (6 in number).Conclusions:The death rate for COVID-19 hospitalized patients is 49.26%. The most prevalent comorbidities in individuals who died as a result of COVID-19 were respiratory syndrome, chronic kidney disease, hypertension, cardiovascular disease, and diabetes.

show abstract

Comorbidity and it,s Impact on COVID-19 Affected Patients in COVID-19 Dedicated Hospital of Bangladesh

Cited by 11 publications

References 25 publications

Death review caused by Covid 19 in Bangladesh

Death review caused by Covid 19 in Bangladesh

Clinical manifestations of hospitalized COVID-19 patients in Bangladesh: a 14-day observational study

The Outcome of Covid-19 Positive Patients in a Covid Dedicated ICU, Associated with Comorbid Diseases: A Cross-Sectional Study

Contact Info

Product

Resources

About